On Monday 2 February the New York State Attorney General’s office sent letters to four major retailers accusing them of selling fraudulent herbal supplements and demanding that they remove the products from their shelves. To the surprise of many analytical chemists, however, the accusations were based on DNA barcoding technology rather than chromatographic analysis.
On Monday 2 February the New York State Attorney General’s office sent letters to four major retailers accusing them of selling fraudulent herbal supplements and demanding that they remove the products from their shelves. To the surprise of many analytical chemists, however, the accusations were based on DNA barcoding technology rather than chromatographic analysis.
The letters said that testing had shown that multiple products of the store brands of the retailers - GNC, Target, Walmart, and Walgreens - contained little or none of the primary ingredient and in many cases showed the presence of other ingredients, such as rice. The products tested included a range of herbal supplements, such as gingko biloba, ginseng, echinacea, and St. John’s wort.
The fact that the DNA testing failed to show evidence of the primary ingredient is not surprising, according to James NealâKababick of Flora Research Laboratories, an independent laboratory in Oregon, USA, that specializes in testing dietary supplements. “The processing that botanical materials undergo when being prepared as supplements often denatures the DNA of the botanical material,” he explained.
This is particularly true of botanical extracts, he said, which typically undergo hydroalcoholic extraction with heat, followed by a spray-drying process. The alcohol generally denatures most of the DNA, and the heat and spray drying often destroys the rest. “You could have an extract that is 99% St. John’s wort and still not see any DNA,” he said. Botanical products prepared as powders may also have their DNA destroyed by heat or heat steam bioburden reduction processes, he added.
The U.S. Pharmacopeia and other standard-setting bodies around the world contain monographs for herbal products that indicate what tests should be used for identity testing. In most cases, the indicated methods include high performance liquid chromatography (HPLC) and highâperformance thin-layer chromatography (HPTLC). “Chromatography should have been the primary technique used in this case,” said Neal-Kababick.“It is mind boggling to me that it wasn’t.”
Neal-Kababick, who has been analyzing supplements for more than 20 years, added that the failure rates for botanical identity tests conducted in his laboratory - which analyzes several hundred such samples a month - are around 5%, nowhere near the 60–100% failures reported in this case.
The fact that the testing revealed DNA of other materials, such as rice, is also not surprising, Neal-Kababick said. Rice is a common excipient in herbal capsules and because of its hard outer coat, can be cleaned simply by washing it, which does not denature its DNA. That is not true for the flowers or leaves of a plant like St. John’s wort, where washing might extract the phytochemical ingredient.
Other material identified in the testing is likely to be small amounts of contaminants, such as insect and other plant material (such as pollen) picked up during harvesting or processing of the botanicals, he added. For food products such as herbs and spices, the U.S. Food and Drug Administration has a “defect action level” that specifies the amount of foreign matter or defective material (such as leaves partly eaten by insects) that is permissible. Likewise, the monographs for herbal supplements in most pharmacopeias include a section on foreign organic matter indicating the types and amounts that are allowed. - L.B.
For more on this story, visit:
www.chromatographyonline.com/supplements-industry-plans-further-testing-products-branded-fraudulent
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.